NCT01125566 LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment Status COMPLETED Phase PHASE3
NCT01122680 Efficacy and Safety of 3 Doses of Tiotropium Compared to Placebo in Adolescents (12 to 17 Yrs) With Moderate Asthma Status COMPLETED Phase PHASE2
NCT01121393 BIBW 2992 (Afatinib) vs Gemcitabine-cisplatin in 1st Line Non-small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE3
NCT01119443 Bioequivalence of Pramipexole Extended Release (PPX ER) 1.5mg x 1 Tablet Once Daily (q.d.) vs. PPX ER 0.375mg x 4 Tablets Under Fasted and Fed Conditions in Japanese Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01111331 Drug Drug Interaction of Empagliflozin (BI 10773) and Warfarin in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01111318 Pharmacokinetics of Empagliflozin (BI 10773) in Patients With Impaired Liver Function Status COMPLETED Phase PHASE1
NCT01108809 Evaluation of the Effect of Telmisartan on Blood Pressure Control of High Risk Patients Status COMPLETED Phase N/A
NCT01108796 Additional Effect of A Life Style Program on Antihypertensive Treatment With Telmisartan Status COMPLETED Phase N/A
NCT01103960 An Eight-week Randomized,Double-blind Study to Evaluate the Efficacy and Safety of Fixed-dose Combinations of T80+A5 Versus A5 Monotherapy in Patients With Hypertension Who Fail to Respond Adequately to Treatment With A5 Monotherapy Status COMPLETED Phase PHASE3
NCT01100073 Kinetic Tremor in Parkinsons Disease: Its Course Under Pramipexole (Mirapexin®) Treatment and Impact on Quality of Life Status COMPLETED Phase N/A
NCT01097421 Influence of Pramipexole Extended Release on Medication Adherence in Parkinson´s Disease Status COMPLETED Phase N/A
NCT01090011 Trial of BIBW 2992 (Afatinib) + Cetuximab in Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE1
NCT01087502 Safety and Efficacy of Linagliptin in Type-2-diabetes Mellitus Patients With Moderate to Severe Renal Impairment Status COMPLETED Phase PHASE3
NCT01085136 LUX-Lung 5: Afatinib Plus Weekly Paclitaxel Versus Investigator's Choice of Single Agent Chemotherapy Following Afatinib Monotherapy in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib Status COMPLETED Phase PHASE3
NCT01084005 Efficacy and Safety of Linagliptin in Elderly Patients With Type 2 Diabetes Status COMPLETED Phase PHASE3